Sofinnova News http://209.237.161.91 Sofinnova News en Copyright 2008 Fri, 13 Apr 2012 00:00:00 +0800 http://www.php.net/ http://blogs.law.harvard.edu/tech/rss <![CDATA[Hyperion Therapeutics Files Registration Statement for Proposed Initial Public Offering]]> http://www.hyperiontx.com/press/release/pr_1334339267

]]> http://www.hyperiontx.com/press/release/pr_1334339267 http://www.hyperiontx.com/press/release/pr_1334339267 Fri, 13 Apr 2012 00:00:00 +0800 <![CDATA[Guavus Sees Analytics As Key To Big Data]]> http://blogs.wsj.com/venturecapital/2012/04/13/guavus-sees-analytics-as-key-to-big-data/?mod=google_news_blog

]]> http://blogs.wsj.com/venturecapital/2012/04/13/guavus-sees-analytics-as-key-to-big-data/?mod=google_news_blog http://blogs.wsj.com/venturecapital/2012/04/13/guavus-sees-analytics-as-key-to-big-data/?mod=google_news_blog Fri, 13 Apr 2012 00:00:00 +0800 <![CDATA[Durata Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering]]> http://www.businesswire.com/news/home/20120322006678/en/Durata-Therapeutics-Files-Registration-Statement-Proposed-Initial

]]> http://www.businesswire.com/news/home/20120322006678/en/Durata-Therapeutics-Files-Registration-Statement-Proposed-Initial http://www.businesswire.com/news/home/20120322006678/en/Durata-Therapeutics-Files-Registration-Statement-Proposed-Initial Thu, 22 Mar 2012 00:00:00 +0800 <![CDATA[Hyperion Therapeutics Acquires Ravicti™ (glycerol phenylbutyrate) from Ucyclyd Pharma, Inc.]]> http://www.hyperiontx.com/press/release/pr_1332470847

]]> http://www.hyperiontx.com/press/release/pr_1332470847 http://www.hyperiontx.com/press/release/pr_1332470847 Thu, 22 Mar 2012 00:00:00 +0800 <![CDATA[Amarin Announces Notification of Patent Allowance for AMR101 ]]> http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=658414

]]> http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=658414 http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=658414 Tue, 20 Mar 2012 00:00:00 +0800